Chae SY - Search Results

1

Protein grafting of p53TAD onto a leucine zipper scaffold generates a potent HDM dual inhibitor.

Lee JH, Kang E, Lee J, Kim J, Lee KH, Han J, Kang HY, Ahn S, Oh Y, Shin D, Hur K, Chae SY, Song PH, Kim YI, Park JC, Lee JI. Lee JH, et al. Among authors: chae sy. Nat Commun. 2014 May 7;5:3814. doi: 10.1038/ncomms4814. Nat Commun. 2014. PMID: 24804811 Free article.

2

Effect of arginine-rich peptide length on the structure and binding strength of siRNA-peptide complexes.

Kim M, Kim HR, Chae SY, Larson RG, Lee H, Park JC. Kim M, et al. Among authors: chae sy. J Phys Chem B. 2013 Jun 13;117(23):6917-26. doi: 10.1021/jp402868g. Epub 2013 May 30. J Phys Chem B. 2013. PMID: 23697608

3

Amelioration of sepsis by TIE2 activation-induced vascular protection.

Han S, Lee SJ, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee YS, Kim D, Lee S, Lee DH, Lee KH, Chae SY, Lee JH, Kim SJ, Kim HC, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Hu J, Song PH, Kim YI, Kim P, Kim I, Koh GY. Han S, et al. Among authors: chae sy. Sci Transl Med. 2016 Apr 20;8(335):335ra55. doi: 10.1126/scitranslmed.aad9260. Sci Transl Med. 2016. PMID: 27099174

4

Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.

Han HS, Lee J, Kim HR, Chae SY, Kim M, Saravanakumar G, Yoon HY, You DG, Ko H, Kim K, Kwon IC, Park JC, Park JH. Han HS, et al. Among authors: chae sy. J Control Release. 2013 Jun 10;168(2):105-14. doi: 10.1016/j.jconrel.2013.02.022. Epub 2013 Mar 6. J Control Release. 2013. PMID: 23474029

5

Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting.

Yoon HY, Kim HR, Saravanakumar G, Heo R, Chae SY, Um W, Kim K, Kwon IC, Lee JY, Lee DS, Park JC, Park JH. Yoon HY, et al. Among authors: chae sy. J Control Release. 2013 Dec 28;172(3):653-61. doi: 10.1016/j.jconrel.2013.09.008. Epub 2013 Sep 17. J Control Release. 2013. PMID: 24055507

6

Improved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligand.

Chae SY, Kim TH, Park K, Jin CH, Son S, Lee S, Youn YS, Kim K, Jo DG, Kwon IC, Chen X, Lee KC. Chae SY, et al. Mol Cancer Ther. 2010 Jun;9(6):1719-29. doi: 10.1158/1535-7163.MCT-09-1076. Epub 2010 Jun 1. Mol Cancer Ther. 2010. PMID: 20515949 Free PMC article.

7

Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.

Jang YL, Yun UJ, Lee MS, Kim MG, Son S, Lee K, Chae SY, Lim DW, Kim HT, Kim SH, Jeong JH. Jang YL, et al. Among authors: chae sy. Int J Pharm. 2012 Sep 15;434(1-2):488-93. doi: 10.1016/j.ijpharm.2012.04.083. Epub 2012 May 14. Int J Pharm. 2012. PMID: 22613208

8

pH-Sensitive pentablock copolymer nanocapsules as nontoxic and efficient gene carriers.

Lee MS, Jang YL, Huynh DP, Huynh CT, Lee Y, Chae SY, Kim SH, Park TG, Lee DS, Jeong JH. Lee MS, et al. Among authors: chae sy. Macromol Biosci. 2011 Jun 14;11(6):789-96. doi: 10.1002/mabi.201000401. Epub 2011 Jan 28. Macromol Biosci. 2011. PMID: 21280227

9

Conjugated chitosan as a novel platform for oral delivery of paclitaxel.

Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY, Jon S. Lee E, et al. Among authors: chae sy. J Med Chem. 2008 Oct 23;51(20):6442-9. doi: 10.1021/jm800767c. Epub 2008 Oct 1. J Med Chem. 2008. PMID: 18826299

10

Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.

Chae SY, Jin CH, Shin JH, Son S, Kim TH, Lee S, Youn YS, Byun Y, Lee MS, Lee KC. Chae SY, et al. J Control Release. 2010 Mar 3;142(2):206-13. doi: 10.1016/j.jconrel.2009.10.025. Epub 2009 Nov 10. J Control Release. 2010. PMID: 19900495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page